Evidence Hub

Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates

Chao Liu, Yao‐Wen Chang, Ying Xin Xu, Yun Luo, Linrong Wu, Zhanjun Mei, Shigang Li, Rui Wang et al.

Oncotarget, 2018

53 citations

Abstract

// Chao Liu 1, * , Yaowen Chang 1, * , Ying Xu 2 , Yun Luo 1 , Linrong Wu 1 , Zhanjun Mei 1 , Shigang Li 1 , Rui Wang 1 and Xu Jia 1 1 Non-coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China 2 Clinical Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China * These authors have contributed equally to this work Correspondence to: Rui Wang, email: [email protected] Xu Jia, email: [email protected] Keywords: Acinetobacter baumannii; antimicrobial resistance; MDR; virulence genes; PFGE Received: December 11, 2017 Accepted: February 26, 2018 Published: April 24, 2018 ABSTRACT Acinetobacter baumannii is undoubtedly one of the most clinically significant pathogens. The multidrug resistance and virulence potential of A. baumannii are responsible for hospital-acquired nosocomial infections. Unlike numerous investigations on the drug-resistant epidemiology of A. baumanni , virulence molecular epidemiology is less studied. Here, we collected 88 A. baumannii clinical isolates, tested their antimicrobial susceptibility to 10 commonly used antibiotics and analyzed the distribution of 9 selected virulence-associated genes, aims to investigate the primary characteristics of the virulence-associated genes that exist in clinically multidrug resistant (MDR) and non-MDR isolates of A. baumannii . The MIC results showed the resistance rates of ciprofloxacin (68.2%, 60/88), gentamicin (67.0%, 59/88),…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free